Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Despite prior objections, the FDA’s newly finalized privacy rule prevents researchers under misconduct investigations from accessing sensitive information on their own proceedings.
Boston Scientific senior vice president Jeff Mirviss writes a scathing criticism of the device tax and applauds Congressional efforts to repeal the 2.3% levy.
Medtech groups laud Sen. Max Baucus (D-Mont.) and Rep. Dave Camp (R-Mich.) for their U.S. tax reform tour, which the industry hopes may become a vehicle for repealing the 2.3% medical device tax.